This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of New Mexico, University of Florida Research Foundation Inc.. Active years: 2014-2022.
Company Filing History:
1 out of 942 
1 out of 3,043 
Years Active: 2014-2022
Title: Robert A Hromas: Innovator in Cancer Therapeutics
Introduction
Robert A Hromas is a prominent inventor based in Gainesville, FL (US), known for his significant contributions to cancer therapeutics. He holds 2 patents that focus on innovative methods for treating various types of cancer. His work has the potential to impact the lives of many patients suffering from this devastating disease.
Latest Patents
Hromas's latest patents include the use of miR-223-3p as a cancer therapeutic and a method for treating cancer using the same. This invention provides a pharmaceutical composition comprising an inhibitory RNA (iRNA) that mediates sequence-specific degradation of the mRNA encoding Poly (ADP-ribose) polymerase 1 (PARP1). The methods described in this patent aim to treat cancers, particularly those with mutations in the BRCA1 and/or BRCA2 genes, including breast cancer, ovarian cancer, prostate cancer, pancreatic cancer, and mesothelioma.
Another notable patent involves bifunctional metnase/intnase inhibitors and related compositions for cancer treatment. This invention focuses on small chemical bifunctional inhibitors of DNA replication and repair proteins Metnase and/or Intnase. These inhibitors are designed to damage DNA and enhance the effectiveness of cancer treatment protocols, including radiation therapy. The methods of treatment can be administered as a monotherapy or in combination with other anti-cancer agents.
Career Highlights
Hromas has worked with esteemed institutions such as the University of Florida Research Foundation Inc and the University of New Mexico. His research has contributed to the advancement of cancer therapies, showcasing his dedication to improving patient outcomes.
Collaborations
Throughout his career, Hromas has collaborated with notable colleagues, including Elizabeth Williamson and Gayathri Srinivasan. These partnerships have fostered innovation and progress in the field of cancer research.
Conclusion
Robert A Hromas is a distinguished inventor whose work in cancer therapeutics is paving the way for new treatment options. His innovative patents and collaborations highlight his commitment to advancing medical science and improving the lives of cancer patients.